Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
1.67 (1y: -36%)
Market Cap 38.95 M P/E(ttm)
Enterprise Value 11.09 M P/B
BLRX- NAS (USA)
Bioline Rx Ltd.
Not Rated
Top Ranked Predictable Companies
$1.67
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
» BLRX's 10-Y Financials

Financials


» Details

Insider Trades

Latest Guru Trades with BLRX



No Insider Trades Found!

Ratios

vs
industry		 vs
history
EV-to-EBIT 250
BLRX's EV-to-EBIT is ranked higher than
100% of the 349 Companies
in the Global Biotechnology industry.

( Industry Median: 14.61 vs. BLRX: 250 )
BLRX' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: 250

Valuation & Return

vs
industry		 vs
history

Business Description

Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Company Website
Industry: Biotechnology
Compare:
Traded in other countries:BLNEF.USA

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK